News LianBio

Equities

LIANY

US53000N1081

Delayed OTC Markets Other stock markets 11:52:18 2024-07-05 am EDT			5-day change	1st Jan Change
0.3152 ^USD	+3.34%		+0.06%	-92.95%

May. 10	China's Zeekr prices US IPO at top of range to raise $441 million	RE
May. 07	Geely's EV Unit Zeekr Targets Up to $367.5 Million From NYSE IPO	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China's Zeekr prices US IPO at top of range to raise $441 million	May. 10	RE
Geely's EV Unit Zeekr Targets Up to $367.5 Million From NYSE IPO	May. 07	MT
LianBio(OTCPK:LIAN.Y) dropped from NASDAQ Composite Index	Mar. 17	CI
ADRs End Lower; Akso Health Group Declines 23%	Mar. 15	DJ
LianBio Announces Voluntarily Delisting from Nasdaq	Feb. 28	AQ
LianBio to Start Winding Down Operations; Complete Dissolution Expected in 2027	Feb. 13	MT
LianBio Announces Completion of Strategic Review	Feb. 13	AQ
LianBio Announces Completion of Strategic Review	Feb. 13	CI
Nanobiotix: transfer of NBTXR3 rights in Asia	Dec. 27	CF
Nanobiotix Partner Transfers Asian Commercialization Rights for Oncology Therapy to Johnson & Johnson Unit	Dec. 27	MT
Sector Update: Health Care Stocks Mixed Premarket Tuesday	Dec. 26	MT
LianBio Assigns Rights to Nanobiotix's Oncology Therapy in China, Other Asian Markets to Janssen Pharmaceutica	Dec. 26	MT
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets	Dec. 26	AQ
LianBio Enters into Agreement with Janssen Pharmaceutica to Assign its Rights for NBTXR3 in China and Other Asian Markets	Dec. 26	CI
Jefferies Downgrades LianBio to Hold From Buy, Adjusts Price Target to $4 From $7	Dec. 22	MT
LianBio Finance Chief Resigns, Names Interim CFO	Dec. 20	MT
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	Dec. 20	MT
LianBio Announces Departure of Chief Financial Officer	Dec. 20	AQ
LianBio Announces Chief Financial Officer Changes	Dec. 20	CI
LianBio CEO Yizhe Wang Resigns; Board Member Adam Stone Named in Interim	Dec. 19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LianBio

Equities

LIANY

US53000N1081

Summary

Filters